+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Spinal Cord Stimulation Devices Market By Product, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • PDF Icon

    Report

  • 258 Pages
  • May 2023
  • Region: Global
  • Allied Market Research
  • ID: 5879259
UP TO OFF until Oct 24th 2024
Spinal cord stimulation is a medical technique that involves the use of an implanted device that delivers electrical impulses to spinal cord, with the aim of reducing pain and improving function in patients with chronic pain conditions. The spinal cord stimulation device consists of a small battery-powered generator that is implanted under the skin, in the lower back and one or more leads that are implanted in the epidural space near the spinal cord. The leads are connected to the generator and deliver electrical impulses to the spinal cord, which interrupt or block pain signals from reaching the brain. Spinal cord stimulation devices are used to treat a variety of conditions, such as failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), degenerative disc disease (DDD), and painful diabetic neuropathy (PDN). Spinal cord stimulation devices are available in different types and designs, with varying features and capabilities. Different types of spinal cord stimulation such as rechargeable and non-rechargeable devices are designed to address different patients’ needs and provide customized treatment options.

The major factors driving the growth of spinal cord stimulation devices market are Increase in number of people suffering from chronic pain conditions, technological advancements in spinal cord stimulation devices, and rise in adoption of spinal cord stimulation devices. Chronic pain can be caused by a variety of conditions, such as failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), degenerative disc disease (DDD), and diabetic neuropathy. These conditions can be debilitating, affecting a person's quality of life and requiring long-term management. Spinal cord stimulation devices have emerged as an effective treatment option for patients suffering from chronic pain conditions who have not responded to other forms of therapy. In addition, spinal cord stimulation devices work by delivering electrical impulses to the spinal cord, disrupting the transmission of pain signals to the brain.

Further, technological advancements in spinal cord stimulation devices have made the devices smaller, flexible, and more effective. For instance, newer devices use high-frequency stimulation, which can provide pain relief without causing the tingling or prickling sensations associated with traditional low-frequency stimulation. In addition, other advances Include the development of rechargeable batteries and wireless devices, which improve patient comfort and convenience. These technological advancements are expected to drive the demand for spinal cord stimulation devices as patients and physicians seek out more effective and user-friendly devices.

Moreover, the world’s population is aging rapidly, and this demographic shift is expected to drive the demand for spinal cord stimulation devices. Older adults are more likely to suffer from chronic pain conditions, and as the population ages, the number of people in need of spinal cord stimulation therapy is expected to grow. For instance, according to the U.S. Census Bureau 2022, more than 56 million adults aged 65 and older live in the U.S., accounting for about 16.9% of the nation’s population; thus, rise in geriatric population is anticipated to fuel the growth of market.

The spinal cord stimulation devices market is segmented into product, indication, end user, and region. On the basis of product, the market is bifurcated into rechargeable devices and non-rechargeable devices. Depending on indication, it is categorized into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease, and others. By end user, it is segregated into hospital, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East Africa)
Major key players that operate in the global spinal cord stimulation devices market are Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Beijing PINS Medical Co., Ltd, Saluda Medical Pty Ltd., Nalu Medical, Inc., BIOTRONIK, GIMER MEDICAL, and Teliatry, Inc. The key players have adopted strategies such as acquisition, product launch, product approval, and expansion to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the spinal cord stimulation devices market analysis from 2022 to 2032 to identify the prevailing spinal cord stimulation devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the spinal cord stimulation devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report Includes the analysis of the regional as well as global spinal cord stimulation devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Indication

  • Failed back surgery syndrome
  • Complex regional pain syndrome
  • Degenerative disc disease
  • Others

By Product

  • Rechargeable devices
  • Non-rechargeable devices

By End User

  • Hospitals
  • Ambulatory surgical centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East Africa

Key Market Players

  • Boston Scientific Corporation
  • Beijing PINS Medical Co., Ltd
  • Medtronic plc
  • Abbott Laboratories
  • BIOTRONIK SE & Co. KG
  • Saluda Medical Pty Ltd.
  • Nalu Medical, Inc.
  • GIMER MEDICAL
  • Teliatry, Inc.
  • Nevro Corporation

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic pain conditions
3.4.1.2. Technological advancements in spinal cord stimulation devices
3.4.1.3. Availability of medical reimbursement schemes
3.4.2. Restraints
3.4.2.1. High cost and side effects of spinal cord stimulation devices
3.4.2.2. Availability of alternative treatment options for chronic pain
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Rechargeable devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Non-rechargeable devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Failed back surgery syndrome
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Complex regional pain syndrome
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Degenerative disc disease
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: SPINAL CORD STIMULATION DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory surgical centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Indication
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Indication
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Indication
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Indication
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Indication
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Indication
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Indication
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Indication
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Indication
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Indication
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Indication
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Indication
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Indication
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Indication
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Indication
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Indication
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Indication
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Indication
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Indication
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Latin America
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Indication
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Middle East Africa
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Indication
7.5.5.2.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Boston Scientific Corporation
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Medtronic plc
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Abbott Laboratories
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Nevro Corporation
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Beijing PINS Medical Co., Ltd
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Saluda Medical Pty Ltd.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Key strategic moves and developments
9.7. Nalu Medical, Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Teliatry, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. GIMER MEDICAL
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Key strategic moves and developments
9.10. BIOTRONIK SE & Co. KG
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Key strategic moves and developments
List of Tables
TABLE 01. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. SPINAL CORD STIMULATION DEVICES MARKET FOR RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. SPINAL CORD STIMULATION DEVICES MARKET FOR NON-RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 05. SPINAL CORD STIMULATION DEVICES MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2022-2032 ($MILLION)
TABLE 06. SPINAL CORD STIMULATION DEVICES MARKET FOR COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2022-2032 ($MILLION)
TABLE 07. SPINAL CORD STIMULATION DEVICES MARKET FOR DEGENERATIVE DISC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 08. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 10. SPINAL CORD STIMULATION DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. SPINAL CORD STIMULATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 18. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 19. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 20. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 21. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 22. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 23. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 24. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 26. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 28. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 29. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 30. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 31. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 32. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 33. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 36. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. UK SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. UK SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 39. UK SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 41. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 42. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 43. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 45. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 54. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 55. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 56. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 57. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 58. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 61. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 73. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 74. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 75. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 76. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 77. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 79. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 80. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 81. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 82. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 84. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 88. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 90. MEDTRONIC PLC: KEY STRATERGIES
TABLE 91. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 92. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 93. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 94. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 95. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 96. NEVRO CORPORATION: KEY EXECUTIVES
TABLE 97. NEVRO CORPORATION: COMPANY SNAPSHOT
TABLE 98. NEVRO CORPORATION: PRODUCT SEGMENTS
TABLE 99. NEVRO CORPORATION: PRODUCT PORTFOLIO
TABLE 100. NEVRO CORPORATION: KEY STRATERGIES
TABLE 101. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
TABLE 102. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
TABLE 103. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
TABLE 104. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
TABLE 105. SALUDA MEDICAL PTY LTD.: KEY EXECUTIVES
TABLE 106. SALUDA MEDICAL PTY LTD.: COMPANY SNAPSHOT
TABLE 107. SALUDA MEDICAL PTY LTD.: PRODUCT SEGMENTS
TABLE 108. SALUDA MEDICAL PTY LTD.: PRODUCT PORTFOLIO
TABLE 109. SALUDA MEDICAL PTY LTD.: KEY STRATERGIES
TABLE 110. NALU MEDICAL, INC.: KEY EXECUTIVES
TABLE 111. NALU MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 112. NALU MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 113. NALU MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 114. TELIATRY, INC.: KEY EXECUTIVES
TABLE 115. TELIATRY, INC.: COMPANY SNAPSHOT
TABLE 116. TELIATRY, INC.: PRODUCT SEGMENTS
TABLE 117. TELIATRY, INC.: PRODUCT PORTFOLIO
TABLE 118. GIMER MEDICAL: KEY EXECUTIVES
TABLE 119. GIMER MEDICAL: COMPANY SNAPSHOT
TABLE 120. GIMER MEDICAL: PRODUCT SEGMENTS
TABLE 121. GIMER MEDICAL: PRODUCT PORTFOLIO
TABLE 122. GIMER MEDICAL: KEY STRATERGIES
TABLE 123. BIOTRONIK SE & CO. KG: KEY EXECUTIVES
TABLE 124. BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
TABLE 125. BIOTRONIK SE & CO. KG: PRODUCT SEGMENTS
TABLE 126. BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
TABLE 127. BIOTRONIK SE & CO. KG: KEY STRATERGIES
List of Figures
FIGURE 01. SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN SPINAL CORD STIMULATION DEVICES MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALSPINAL CORD STIMULATION DEVICES MARKET
FIGURE 10. SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR RECHARGEABLE DEVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR NON-RECHARGEABLE DEVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR COMPLEX REGIONAL PAIN SYNDROME, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR DEGENERATIVE DISC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. SPINAL CORD STIMULATION DEVICES MARKET BY REGION, 2022
FIGURE 23. U.S. SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 24. CANADA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 25. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 26. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 27. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 28. UK SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 29. ITALY SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 30. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 31. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 32. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 33. CHINA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 34. INDIA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 35. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 36. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 37. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 38. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 39. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44. COMPETITIVE DASHBOARD
FIGURE 45. COMPETITIVE HEATMAP: SPINAL CORD STIMULATION DEVICES MARKET
FIGURE 46. TOP PLAYER POSITIONING, 2022
FIGURE 47. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 48. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 49. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 50. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 51. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. NEVRO CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 57. NEVRO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

Executive Summary

According to a new report, titled, 'Spinal Cord Stimulation Devices Market,' The spinal cord stimulation devices market was valued at $2.1 billion in 2022, and is estimated to reach $4.8 billion by 2032, growing at a CAGR of 8.4% from 2023 to 2032.

A spinal cord stimulation device is surgically implanted under the skin, typically in the lower back or buttock area, and uses electrical impulses to help alleviate chronic pain. The device works by delivering a low-voltage electrical current to the spinal cord, which interrupts pain signals traveling from the spinal cord to the brain. The major factors driving the growth of spinal cord stimulation devices market are increasing prevalence of chronic pain, favorable reimbursement policies and growing aging population. Chronic pain conditions such as failed back surgery syndrome, complex regional pain syndrome, and neuropathic pain are becoming more common. For instance, Canadian Pain Task Force Report 2021, stated that, chronic pain is major problem, and projections indicate as many as 8.3 million Canadians may live with chronic pain by 2025 & as many as 9.0 million by 2030, thereby driving the demand for spinal cord stimulation devices.

Spinal cord stimulation devices provide a non-pharmacological approach to managing chronic pain, offering an alternative to opioid-based pain management. Further, global population is aging, leading to increased risk of chronic pain conditions such as degenerative disc disease, and spinal stenosis. As the elderly population expands, the demand for effective pain management solutions such as spinal cord stimulation devices rises. Furthermore, advancements in technology have played a crucial role in the growth of the spinal cord stimulation devices market. Modern spinal cord stimulation devices offer a wide range of programming features, including the ability to target specific areas of pain, adjust stimulation parameters, and provide personalized therapy. These advancements have led to improved patient outcomes, enhanced pain relief, and increased patient satisfaction. Moreover, the development of rechargeable batteries has extended the lifespan of spinal cord stimulation devices, reducing the need for frequent battery replacements and enhancing patient convenience. Technological advancements have made spinal cord stimulation devices more effective, user-friendly and durable, thereby fueling their adoption and market growth.

In addition, the growing awareness and education about spinal cord stimulation devices therapy in emerging markets play a vital role in its adoption. Healthcare professionals, patient advocacy groups, and medical societies are actively involved in spreading awareness and providing education about the benefits of spinal cord stimulation devices therapy. This increased knowledge and understanding among healthcare providers and patients contribute to the acceptance and adoption of spinal cord stimulation devices therapy in these markets.

Moreover, reimbursement policies and coverage play a vital role in the adoption of medical devices, including spinal cord stimulation devices. In many regions such as North America, governments and insurance providers have recognized the clinical effectiveness of spinal cord stimulation in managing chronic pain and have implemented favorable reimbursement policies. These policies ensure that a significant portion of the cost associated with spinal cord stimulation devices and implantation procedures is covered, making them more accessible to patients. The availability of reimbursement encourages healthcare providers to recommend spinal cord stimulation devices as a viable treatment option, as patients can afford the associated costs, thereby propelling the growth of market.

The spinal cord stimulation devices market is segmented into product, indication, end user, and region. Based on product, the market is bifurcated into rechargeable devices and non-rechargeable devices. Depending on indication, it is categorized into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease and others. By end user, it is segregated into hospital, ambulatory surgical centers and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East Africa).

The key players profiled in the study include Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Beijing PINS Medical Co., Ltd, Saluda Medical Pty Ltd., Nalu Medical, Inc., BIOTRONIK, GIMER MEDICAL, and Teliatry, Inc.

Key Market Insights

  • By product, the rechargeable devices segment accounted for largest share in terms of revenue in 2022 and expected to register highest CAGR during the forecast period.
  • Based on indication, the failed back surgery syndrome segment was the major shareholder in terms of revenue in 2022. However, the degenerative disk disease segment is anticipated to register highest CAGR during the forecast period.
Depending on end user, the hospitals segment garnered the largest share in terms of revenue in 2022 and anticipated to register highest CAGR during the forecast period.
  • Region wise, North America occupied the largest share in terms of revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Boston Scientific Corporation
  • Beijing PINS Medical Co., Ltd
  • Medtronic plc
  • Abbott Laboratories
  • BIOTRONIK SE & Co. KG
  • Saluda Medical Pty Ltd.
  • Nalu Medical, Inc.
  • GIMER MEDICAL
  • Teliatry, Inc.
  • Nevro Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...